GSK
GSK
GSK
774 hedge funds and large institutions have $11.3B invested in GSK in 2021 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 300 increasing their positions, 292 reducing their positions, and 89 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
0.22% more ownership
Funds ownership: 4.81% → 5.04% (+0.22%)
5% less funds holding
Funds holding: 818 → 774 (-44)
39% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 89
Holders
774
Holding in Top 10
10
Calls
$152M
Puts
$116M
Top Buyers
| 1 | +$893M | |
| 2 | +$251M | |
| 3 | +$124M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$81.1M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$76.7M |
Top Sellers
| 1 | -$197M | |
| 2 | -$196M | |
| 3 | -$177M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$161M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$78.9M |